title: Effect of the 5-lipoxygenase inhibitors EP 10045 and EP 10161 on cardiac graft cellular infiltrate and thromboxane formation.
authors.affiliation: Department of Surgery, Georgetown University Medical Center, Washington, DC.
authors.forename: L K
authors.initials: LK
authors.lastname: Lim
authors.forename: B S
authors.initials: BS
authors.lastname: Khirabadi
authors.forename: P
authors.initials: P
authors.lastname: Braquet
authors.forename: P W
authors.initials: PW
authors.lastname: Ramwell
authors.forename: M L
authors.initials: ML
authors.lastname: Foegh
mesh_terms: D000818:Animals; D001091:Arachidonate Lipoxygenases / Q000037:antagonists & inhibitors*; D001578:Benzopyrans / Q000494:pharmacology*; D002396:Catechols / Q000494:pharmacology*; D002839:Chromans / Q000494:pharmacology*; D003524:Cyclosporins / Q000494:pharmacology; D006084:Graft Rejection / Q000187:drug effects*; D016027:Heart Transplantation; D007962:Leukocytes / Q000473:pathology; D016859:Lipoxygenase Inhibitors; D009206:Myocardium / Q000276:immunology / Q000473:pathology; D051381:Rats; D013440:Sulfides / Q000494:pharmacology*; D013929:Thromboxane B2 / Q000096:biosynthesis*
chemical_list: D001578:Benzopyrans; D002396:Catechols; D002839:Chromans; D003524:Cyclosporins; D016859:Lipoxygenase Inhibitors; D013440:Sulfides; C047171:methyl-2-butylmercapto-4-catechol; C055752:EP 10161; D013929:Thromboxane B2; D001091:Arachidonate Lipoxygenases